Načítá se...
Precautions for Patients Taking Aromatase Inhibitors
Aromatase inhibitors are the drug of choice for the treatment of estrogen receptor– or progesterone receptor–positive breast cancer in postmenopausal women. Aromatase is an enzyme that catalyzes the final and rate-limiting step in the biosynthesis of estrogen. Inhibitors of this enzyme are an effect...
Uloženo v:
| Vydáno v: | J Adv Pract Oncol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Harborside Press LLC
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7848814/ https://ncbi.nlm.nih.gov/pubmed/33532117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2020.11.2.6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|